Cargando…

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

Background: Familial amyloid polyneuropathy related to transthyretin gene (TTR-FAP) is a life-threatening disease transmitted as an autosomal dominant trait. Val30Met mutation accounts for the majority of the patients with large endemic foci especially in Portugal, Sweden and Japan. However, more th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzeo, Anna, Russo, Massimo, Di Bella, Gianluca, Minutoli, Fabio, Stancanelli, Claudia, Gentile, Luca, Baldari, Sergio, Carerj, Scipione, Toscano, Antonio, Vita, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2015
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271421/ https://www.ncbi.nlm.nih.gov/pubmed/27858761 http://dx.doi.org/10.3233/JND-150091

Ejemplares similares

TTR-FAP: a single-center experience in Sicily, an Italian endemic area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis
por: Di Bella, Gianluca, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

Usefulness of combining electrocardiogram and echocardiography findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation
por: Di Bella, Gianluca, et al.
Publicado: (2015)

Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan
por: Miyake, Zenshi, et al.
Publicado: (2018)

Parenteral nutrition improves nutritional status, autonomic symptoms and QoL in patients with TTR-FAP
por: Russo, Massimo, et al.
Publicado: (2015)

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
por: Parman, Yesim, et al.
Publicado: (2016)

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
por: Lipowska, Marta, et al.
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

The diagnostic accuracy of Sudoscan in TTR-FAP
por: Castro, Jose, et al.
Publicado: (2015)

Therapeutic education programme in TTR-FAP
por: Théaudin, Marie, et al.
Publicado: (2015)

Is 99mTc-diphosphonate uptake the earliest sign of cardiac amyloidosis development in asymptomatic Glu89Gln transthyretin gene mutation carriers?
por: Minutoli, Fabio, et al.
Publicado: (2015)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

Retinal and choroidal vascular abnormalities in TTR-FAP
por: Rousseau, Antoine, et al.
Publicado: (2015)

Preimplantation genetic diagnosis for TTR-FAP in Portugal
por: Carvalho, Filipa
Publicado: (2015)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Management of stage 1 TTR FAP: French experience
por: Adams, David, et al.
Publicado: (2015)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Emerging CNS involvement in FAP-TTR long survival patients
por: Maia, Luisa
Publicado: (2015)

Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis
por: Licordari, Roberto, et al.
Publicado: (2021)

Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
por: Yarlas, Aaron, et al.
Publicado: (2021)

Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
por: Chequer, Renata, et al.
Publicado: (2015)

TTR-FAP: liver transplant vs oral medication. How and when
por: Coelho, Teresa
Publicado: (2015)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area
por: Russo, Massimo, et al.
Publicado: (2021)

When to decide to enroll a TTR-FAP patient in a Clinical Trial?
por: Buades, Juan
Publicado: (2015)

Specific ocular changes in TTR Met30-FAP after liver transplantation
por: Ferreira, Natalia, et al.
Publicado: (2015)

Axon reflex–mediated vasodilation is reduced in proportion to disease severity in TTR-FAP
por: Calero-Romero, Irène, et al.
Publicado: (2018)

Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR
por: Yarlas, Aaron, et al.
Publicado: (2021)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
por: Rousseau, Antoine, et al.
Publicado: (2015)

Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
por: Romero-Imbroda, Jesús, et al.
Publicado: (2017)

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H., et al.
Publicado: (2018)

Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy
por: Fernandes, Armindo, et al.
Publicado: (2019)

A phase 3 clinical trial with ISIS-TTRRx, a 2nd-generation antisense oligonucleotide targeting transthyretin (TTR), for the treatment of TTR amyloid cardiomyopathy
por: Millns, Helen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eef1a0faau3qo773ta4kgercbg